Cargando…
Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study
AIM: To evaluate the prognostic value of the tumor-stroma ratio (TSR) in rectal cancer. METHODS: TSR was determined on hematoxylin and eosin stained histological sections of 154 patients treated for rectal adenocarcinoma without prior neoadjuvant treatment in the period 1996-2006 by two observers to...
Autores principales: | Scheer, René, Baidoshvili, Alexi, Zoidze, Shorena, Elferink, Marloes A G, Berkel, Annefleur E M, Klaase, Joost M, van Diest, Paul J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740087/ https://www.ncbi.nlm.nih.gov/pubmed/29290917 http://dx.doi.org/10.4251/wjgo.v9.i12.466 |
Ejemplares similares
-
Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019) -
Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022) -
Prognostic value of claudin 18.2 expression in gastric adenocarcinoma
por: Kayikcioglu, Erkan, et al.
Publicado: (2023) -
Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients
por: Xie, Jie-Bin, et al.
Publicado: (2021) -
Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2021)